Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FH5FR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $64,617
Award facts
- Contract value 100% obligated
- $64,617.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, issued on September 26, 2025, awards DMS Pharmaceutical Group Inc. a firm fixed-price contract valued at $64,617.44 for the supply of Stelara 90 mg/mL syringes. The award was made by the Defense Logistics Agency (DLA), the Department of Defense's primary logistics support agency, with performance scheduled through October 20, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order from its headquarters location. The contract includes no set-aside designation, allowing the vendor to compete on an unrestricted basis in the federal procurement marketplace.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a comprehensive pharmaceutical supply vehicle valued at $499,999,999 and extending through November 2026. The IDC enables the DLA to procure a broad spectrum of pharmaceutical products, including prescription medications, biologics, and medical consumables to support military healthcare facilities worldwide. Stelara, a biologic immunosuppressant medication, represents one of the specialized pharmaceutical products within the company's extensive portfolio of federal supply contracts. This arrangement positions DMS Pharmaceutical Group as a critical supplier within the federal pharmaceutical distribution network serving Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FH5FR?
SPE2DB25FH5FR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FH5FR worth?
The government has obligated $64,617 on SPE2DB25FH5FR.
Is contract SPE2DB25FH5FR an order under another contract?
Yes. SPE2DB25FH5FR is a delivery order under SPE2DB22D9207, an indefinite delivery contract.
Was contract SPE2DB25FH5FR competed?
The extent of competition for SPE2DB25FH5FR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award